Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The report highlights that the company has made significant progress in its overseas clinical trials, which enhances the probability of success for its long-term pipeline [1] - The revenue forecast for 2025 has been adjusted upwards to 0.02 billion, 0.64 billion, and 2.03 billion for the years 2025, 2026, and 2027 respectively, indicating a positive outlook [1] - The target price has been raised to 29.26 HKD, reflecting increased confidence in the company's pipeline success [1] Financial Performance Summary - Total revenue for 2023 is projected at 56.69 million, with a year-on-year growth of 4.81% [1] - The net profit attributable to the parent company is expected to be negative at (144.72) million for 2023, with a year-on-year increase of 54.04% [1] - The earnings per share (EPS) for 2025 is estimated at (0.43) HKD, with a price-to-earnings (P/E) ratio of (18.70) [1] Pipeline Development - ASC30, the company's core GLP-1 pipeline, is currently in Phase IIa clinical trials in the US, with expected top-line data release in Q4 2025 [1] - ASC47, a new THR-β target pipeline, is also in clinical trials, with data expected in Q4 2025 [1] - ASC50, an oral small molecule for psoriasis, is in Phase I clinical trials, with top-line data anticipated by the end of 2025 [1] - The company has a strong cash position of 1.58 billion at the end of H1 2025, which supports ongoing research and development [1]

Investment Rating - The report maintains a "Buy" rating for NetEase Cloud Music (9899.HK) [4] Core Insights - The company reported a slight revenue miss but exceeded profit expectations due to a reduction in sales expenses. Revenue for 1H25 was RMB 38.3 billion, down 6% year-over-year, compared to Bloomberg's consensus estimate of RMB 39.1 billion. Gross profit reached RMB 13.9 billion, with a gross margin of 36.4%, an increase of 1.4 percentage points year-over-year. Operating profit was RMB 8.45 billion, up 40.8% year-over-year, primarily due to reduced sales expenses. Adjusted net profit attributable to shareholders was RMB 19.5 billion, a significant increase of 121% year-over-year, mainly due to the recognition of deferred tax assets amounting to RMB 8.5 billion [1][4] Revenue Breakdown - Online music service revenue for 1H25 was RMB 29.7 billion, reflecting a year-over-year growth of 15.9%. Subscription revenue grew by 15.2% to RMB 24.7 billion, driven by an increase in membership subscriptions, while social entertainment services and other revenues fell by 43.1% to RMB 8.6 billion due to the closure of the live streaming entry after the 2024 year-end version update [2][3] User Engagement and Product Development - The platform continues to enhance user engagement through product innovation and community ecosystem improvements. The NetEase Cloud Music app has introduced features such as personalized recommendations and AI functionalities, maintaining a daily active users to monthly active users ratio (DAU/MAU) above 30% [3] Cost Management - The company has effectively controlled costs, with sales expenses decreasing by 55.8% year-over-year to RMB 1.63 billion, attributed to a cautious promotional strategy. Management expenses increased by 3.6% to RMB 930 million, while R&D expenses decreased by 4.2% to RMB 3.79 billion [3] Profit Forecast and Valuation - The adjusted net profit forecast for 2025 has been raised to RMB 29.4 billion, a 55% increase from previous estimates. The adjusted net profit for 2026 and 2027 is also revised upward to RMB 25.9 billion and RMB 28.6 billion, representing increases of 19% and 17% respectively [4][5]

Investment Rating - The investment rating for the company is "Buy" and is maintained [7] Core Viewpoints - The company reported a total revenue of 3.19 billion yuan for the first half of 2025, a year-on-year decrease of 23.9%, primarily due to uneven scheduling of film projects by New Classics Media [2][4] - The gross profit was 1.61 billion yuan, down 22.6% year-on-year, but the gross margin increased by 0.8 percentage points to 50.5% [2][4] - The net profit attributable to shareholders was 850 million yuan, an increase of 68.5% year-on-year, while the Non-IFRS net profit was 508 million yuan, a decrease of 27.7% [2][4] Revenue Breakdown - In the first half of 2025, revenue from copyright operations and other businesses was 1.205 billion yuan, a decrease of 46.4% year-on-year, with copyright revenue down 48.4% to 1.138 billion yuan due to no new film releases from New Classics Media [8] - Online business revenue totaled 1.985 billion yuan, a year-on-year increase of 2.3%, with self-owned platform product revenue at 1.746 billion yuan, up 3.1% [8] - Revenue from Tencent product channels decreased by 25.6% to 97 million yuan, while third-party platform revenue increased by 23.1% to 142 million yuan [8] IP Ecosystem Growth - The company saw explosive growth in its IP content ecosystem, adding approximately 200,000 new authors and 410,000 new novels, with a total of 20 billion new words created [8] - The number of new signed works generating over 1 million yuan in revenue increased by 63% year-on-year, and the number of new authors achieving average subscriptions over 10,000 increased by 45% [8] - The company launched over 2,000 web literature IPs for high-quality short dramas, with the first batch of 300 IPs released [8] AI and Overseas Expansion - The company introduced the "Miaobi Tongjian," an AI writing assistant that improved interaction frequency with authors by 40% and increased daily active users by over 40% [8] - Revenue from AI-translated works on the overseas reading platform WebNovel grew by 38% year-on-year, accounting for over 35% of total novel revenue on the platform [8]

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of 5% to 15% over the next 6 to 12 months [6][13]. Core Insights - The company reported a revenue of HKD 27.36 billion for H1 2025, a year-on-year decrease of 6.5%, while the net profit attributable to shareholders was HKD 7.709 billion, reflecting a year-on-year increase of 27.5% [2][4]. - The growth in net profit was primarily driven by a significant increase in profits from property development in Hong Kong, which rose by 219% year-on-year, contributing to an overall EBIT of HKD 10.2 billion, up 31% [4][5]. - The company is actively pursuing 10 residential property development projects, with expected profits from these projects to continue in H2 2025 [5]. Financial Performance - Revenue breakdown for H1 2025 shows: - Hong Kong transport operations: HKD 11.5 billion, up 3.3% year-on-year - Hong Kong station commercial: HKD 2.6 billion, down 0.6% - Mainland China and international business: HKD 10.2 billion, down 18.1% - Hong Kong property leasing and management: HKD 2.7 billion, down 1.2% [3][4]. - The company’s EBIT margin improved by 1 percentage point to 37%, with a net profit margin increase of 8 percentage points to 28% [4]. Earnings Forecast - The company’s net profit forecasts for 2025 to 2027 are HKD 17.1 billion, HKD 17.4 billion, and HKD 12.3 billion, respectively [6].

Investment Rating - The report initiates coverage on Yuehai Investment with a "Buy" rating and sets a target price of HKD 9.10, corresponding to a 2025 target PE of 14.0 times [1][7]. Core Views - Yuehai Investment is a high-quality water utility platform controlled by Guangdong state-owned assets, with its core asset being the Dongshen Water Supply Project, which has undergone significant structural changes since 1997 [1]. - The company has a strong free cash flow and is expected to maintain high dividend returns following the divestment of Yuehai Land [1][19]. Summary by Sections Investment Highlights - The Dongshen Water Supply Project is a premium asset, accounting for nearly 80% of Hong Kong's freshwater supply, with a projected revenue of HKD 63.60 billion in 2024, representing 34% of total revenue [20]. - The company has turned positive in free cash flow since 2023, with projections of HKD 92.29 billion in 2024, and maintains a high dividend payout ratio of 65% [21]. - The divestment of Yuehai Land allows the company to focus on its core water business, enhancing stability and potentially increasing valuation [22]. Valuation and Financial Projections - The DCF valuation of the Dongshen Water Supply Project is estimated between HKD 450 billion and HKD 620 billion, with a stable profit contribution from other water resources and businesses [2][23]. - The forecasted net profit for 2025-2027 is HKD 42.18 billion, HKD 43.97 billion, and HKD 45.76 billion, with corresponding EPS of HKD 0.65, HKD 0.67, and HKD 0.70 [5][11]. Market Perspective - The report contrasts with market concerns regarding the uncertainty of the Dongshen project's operating rights renewal, water pricing, and transaction pricing, asserting that the renewal visibility is strong due to the project's historical significance [4][23]. - The report emphasizes that the water pricing will remain reasonable despite rising costs, as the Hong Kong Water Supplies Department aims to adjust water pricing cautiously [4][23].

Investment Rating - The report initiates coverage with a "Buy" rating for the company [4] Core Insights - The company is recognized as a leading high-end beauty group in China, with strong revenue growth and high profitability [1][4] - The brand MGP is the only domestic brand among the top fifteen high-end beauty brands in China, indicating a unique market position [1][33] - The company is expected to achieve significant revenue growth driven by product matrix expansion and systematic channel development [4] Summary by Sections Company Overview - The company was founded in 2000 by renowned makeup artist Mao Geping and operates two major beauty brands, MGP and "Zhi Ai Zhong Sheng," along with makeup training services [13][16] - The company has shown impressive revenue growth from 1.58 billion RMB in 2021 to 3.88 billion RMB in 2024, with a CAGR of 35.0% [17][1] Brand Value - The brand value of MGP is expected to continue to rise, supported by its unique positioning and strong consumer recognition [2][33] - MGP has established a solid reputation in the market, with flagship products achieving significant sales, such as the "Light and Shadow" powder series and luxury caviar masks [2][35] Growth Drivers - The company's growth is primarily driven by the expansion of its product matrix and the establishment of a systematic channel strategy [3][4] - The product range includes makeup, skincare, and upcoming fragrance lines, with a focus on high-quality offerings tailored to Chinese consumers [3][20] Financial Forecast and Investment Recommendations - Revenue projections for 2025-2027 are estimated at 5.15 billion, 6.68 billion, and 8.43 billion RMB, respectively, with corresponding growth rates of 32.6%, 29.6%, and 26.2% [4][5] - The company is expected to maintain high profitability, with a gross margin of 84.4% and a net profit margin of 22.7% in 2024 [1][4]

Investment Rating - The report maintains a "Buy" rating for NetEase Cloud Music, with a target price updated to 312 HKD for 2026, based on a PE of 28X [5][25]. Core Insights - The company's subscription business is experiencing steady growth, significantly reducing promotional and advertising expenses. The financial structure is improving, and the trend towards commercialization is positive [3][11]. - The report highlights that the online music business is growing healthily, while the social entertainment segment is under pressure [21][25]. Financial Summary - Revenue projections for 2023A to 2027E are as follows: 7,867 million RMB in 2023, 7,950 million RMB in 2024, 7,902 million RMB in 2025, 8,649 million RMB in 2026, and 9,375 million RMB in 2027, with a growth rate of -12.5% in 2023 and a projected increase of 9.5% in 2026 [4][25]. - Gross profit is expected to rise from 2,103 million RMB in 2023A to 3,807 million RMB in 2027E, with gross margin improving from 26.7% to 40.6% over the same period [4][25]. - Adjusted net profit is forecasted to be 819 million RMB in 2023, increasing to 2,458 million RMB by 2027, with a significant jump of 107.7% in 2024 [4][25]. Business Performance Overview - In the first half of 2025, the company achieved a revenue of 38.3 billion RMB, a year-on-year decrease of 6.0%. The gross margin was 36.4%, reflecting a year-on-year increase of 1.4 percentage points [25]. - Online music revenue reached 29.7 billion RMB, up 15.9% year-on-year, with subscription revenue growing by 15.2% to 24.7 billion RMB [21][25]. - The social entertainment and other business revenues faced a decline of 43.1% year-on-year, totaling 8.6 billion RMB [21][25]. User Engagement and Community Growth - The report notes a steady increase in monthly active users, with improvements in user engagement metrics such as DAU/MAU ratios and listening duration [25]. - As of June 2025, the platform has over 819,000 registered independent musicians, contributing approximately 4.8 million music tracks [25]. Profitability Forecast and Investment Recommendations - The adjusted net profit for 2025-2027 is projected at 27.58 billion RMB, 22.22 billion RMB, and 24.58 billion RMB, respectively, indicating a growth of 62.3% in 2025, followed by a decline of 19.5% in 2026, and a recovery of 10.6% in 2027 [25]. - The report emphasizes the high entry barriers in the online music service industry and the stable competitive landscape, suggesting significant potential for profitability improvement for NetEase Cloud Music [25].

Investment Rating - The report maintains an "Accumulate" rating for the company with a target price of HKD 29.90 [1][5][32] Core Views - The company reported a revenue of HKD 27.4 billion for the first half of 2025, a decrease of 6.5% year-on-year, while the net profit attributable to shareholders was HKD 7.709 billion, an increase of 27.5% year-on-year. However, the recurring profit was below expectations at HKD 3.391 billion, down 15.7% year-on-year [1][5] - The property development segment is experiencing a harvest period, with profits from property development reaching HKD 5.542 billion, up 218.5% year-on-year, driven by the recovery of the Hong Kong property market [1][4] - The report highlights the challenges faced by the Hong Kong rail operations due to rising operational costs, with EBIT down 76% year-on-year despite a revenue increase of 3.3% [2][3] Summary by Sections Financial Performance - The company’s revenue for 1H25 was HKD 27.4 billion, a decrease of 6.5% year-on-year, while net profit attributable to shareholders was HKD 7.709 billion, an increase of 27.5% year-on-year. The recurring profit was HKD 3.391 billion, which was 9% lower than expectations [1][5] - The company plans to distribute an interim dividend of HKD 0.42 per share, unchanged from the previous year [1] Operational Insights - The Hong Kong rail operations generated revenue of HKD 11.5 billion in 1H25, up 3.3% year-on-year, but EBIT fell to HKD 0.98 billion, down 76% year-on-year due to increased employee costs and inflation [2] - The report notes that the new rental rates for shops in the Hong Kong stations continued to decline, with a drop of 7.0% year-on-year [3] Property Development - The property development segment recorded a net profit of HKD 5.542 billion, primarily from projects in the Whampoa area, with a significant increase attributed to a low base from the previous year [4] - The report indicates that the Hong Kong property market is showing signs of recovery, with a 0.6% increase in the private residential price index over three consecutive months [4] Profit Forecast and Valuation - The report adjusts the net profit forecasts for 2025-2027 downwards by 11%, 3%, and 17% to HKD 18.1 billion, HKD 21 billion, and HKD 11 billion respectively [5][31] - The valuation is based on a discounted cash flow (DCF) method with a WACC of 7.0% and a perpetual growth rate of 3%, leading to a target price of HKD 29.90 per share [5][32]

Investment Rating - The report downgrades the investment rating to "Outperform" [2][6] Core Views - The company reported a revenue of 98.5 billion yuan in the first half of 2025, representing a year-on-year growth of 14.1%, with external customer revenue reaching 66.1 billion yuan, up 10.2% [6] - The integrated supply chain business has driven revenue growth, with a 19.9% increase in revenue from this segment, contributing significantly to overall growth [6] - Employee costs have risen alongside business expansion, with the number of employees exceeding 660,000 and employee costs increasing by 17.1% to 35 billion yuan [6] - The report maintains profit forecasts, expecting adjusted net profits of 83.07 billion yuan, 91.66 billion yuan, and 105.13 billion yuan for 2025, 2026, and 2027 respectively, with corresponding PE ratios of 10, 9, and 8 [6][7] Financial Data and Profit Forecast - Revenue (million yuan): 2023: 166,625; 2024: 182,838; 2025E: 204,215; 2026E: 225,948; 2027E: 247,880 [3] - Adjusted Net Profit (million yuan): 2023: 2,761; 2024: 7,917; 2025E: 8,307; 2026E: 9,166; 2027E: 10,513 [3] - Earnings per Share (yuan/share): 2023: 0.44; 2024: 1.25; 2025E: 1.31; 2026E: 1.45; 2027E: 1.66 [3] - Return on Equity (%): 2023: 5.73%; 2024: 14.31%; 2025E: 13.23%; 2026E: 12.86%; 2027E: 12.96% [3] Market Data - Closing price (HKD): 13.96 [4] - Market capitalization (billion HKD): 928.07 [4] - 52-week high/low (HKD): 16.84/7.68 [4]

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The overseas sales of Furquatinin are strong, and the potential of the ATTC platform is promising [5] - The company has adjusted its full-year guidance for oncology business to USD 270-350 million based on strong sales performance [7] - The unique ATTC platform is expected to overcome resistance to targeted therapies and reduce toxicity, with several potential pipelines in development [7] Financial Performance - For the first half of 2025, the company reported total revenue of USD 278 million, with oncology and autoimmune business contributing USD 144 million and other business USD 134 million [7] - The revenue from Furquatin overseas reached USD 43.1 million, with a year-on-year growth of 25% [7] - The company forecasts total revenue of USD 580 million, USD 713 million, and USD 901 million for 2025, 2026, and 2027 respectively [8] Earnings Forecast and Valuation - The projected net profit for 2025 is USD 427 million, with a significant year-on-year growth of 1032.3% [6] - The estimated earnings per share for 2025 is USD 0.49, with a projected P/E ratio of 6.69 [6] - The company's fair equity value is estimated at HKD 28 billion, assuming a perpetual growth rate of 2% and a WACC of 9.43% [7]